Immune-checkpoint inhibitors and neurological adverse events
Immune-checkpoint inhibitors and neurological adverse events
About this item
Full title
Author / Creator
Publisher
England: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
Initial diagnostic investigations in people with neurological symptoms after use of immune-checkpoint inhibitors are geared towards prompt exclusion of differential diagnoses, especially tumour recurrence in the nervous system and potentially treatable infections and metabolic conditions; alternative diagnoses were excluded for patients in the stud...
Alternative Titles
Full title
Immune-checkpoint inhibitors and neurological adverse events
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2891759140
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2891759140
Other Identifiers
ISSN
1474-4422
E-ISSN
1474-4465
DOI
10.1016/S1474-4422(23)00413-1
